Tharimmune, Inc.
THAR
$1.21
-$0.0002-0.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.04M | 5.82M | 5.59M | 5.55M | 5.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.43M | 11.12M | 9.10M | 9.09M | 9.46M |
| Operating Income | -12.43M | -11.12M | -9.10M | -9.09M | -9.46M |
| Income Before Tax | -12.20M | -10.85M | -8.88M | -8.89M | -9.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.20 | -10.85 | -8.88 | -8.89 | -9.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.20M | -10.85M | -8.88M | -8.89M | -9.32M |
| EBIT | -12.43M | -11.12M | -9.10M | -9.09M | -9.46M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -9.89 | -18.44 | -55.41 | -105.06 | -189.73 |
| Normalized Basic EPS | -6.18 | -11.53 | -34.63 | -65.66 | -118.58 |
| EPS Diluted | -9.89 | -18.44 | -55.41 | -105.06 | -189.73 |
| Normalized Diluted EPS | -6.18 | -11.53 | -34.63 | -65.66 | -118.58 |
| Average Basic Shares Outstanding | 5.08M | 3.52M | 2.02M | 1.11M | 353.10K |
| Average Diluted Shares Outstanding | 5.08M | 3.52M | 2.02M | 1.11M | 353.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |